News

ahajournals.org17d
The Art of MicroRNA Research
These target prediction programs use several characteristics to determine whether a miRNA can potentially target an mRNA. The 5′ seed region of the miRNA (bases 2 to 8) must show sequence ...
manilatimes23d
UTR Therapeutics Inc Announces IND submission to the US FDA for a First-in-Human Clinical Trial of an mRNA destabilizing drug targeting c-MYC driven cancers
Chief Medical Officer (Adult Cancers), UTRx Inc. "The validation data supports the technological abilities of engineering mRNA stability elements on the 3'UTR of oncogenes for therapeutic use,” said ...
BioSpace23d
UTR Therapeutics Inc Announces IND submission to the US FDA for a First-in-Human Clinical Trial of an mRNA destabilizing drug targeting c-MYC driven cancers
Chief Medical Officer (Adult Cancers), UTRx Inc. “The validation data supports the technological abilities of engineering mRNA stability elements on the 3’UTR of oncogenes for therapeutic use,” said ...
The Hamilton Spectator24d
UTR Therapeutics Inc Announces IND submission to the US FDA for a First-in-Human Clinical Trial of an mRNA destabilizing drug targeting c-MYC driven cancers
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) — UTR Therapeutics Inc (UTRx Inc.), a drug development biotech company based in New York City, USA is pleased to announce a new milestone, the submission ...